Viemed Healthcare Retained Earnings Over Time
| VMD Stock | USD 8.65 0.06 0.69% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Viemed Healthcare Performance and Viemed Healthcare Correlation. Viemed |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viemed Healthcare. If investors know Viemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viemed Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.425 | Earnings Share 0.25 | Revenue Per Share 5.534 | Quarterly Revenue Growth 0.174 | Return On Assets 0.0686 |
The market value of Viemed Healthcare is measured differently than its book value, which is the value of Viemed that is recorded on the company's balance sheet. Investors also form their own opinion of Viemed Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Viemed Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viemed Healthcare's market value can be influenced by many factors that don't directly affect Viemed Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viemed Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viemed Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viemed Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Retained Earnings Analysis
Compare Viemed Healthcare and related stocks such as Profound Medical Corp, Si Bone, and IRIDEX Retained Earnings Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PROF | (453.2 K) | (453.2 K) | (453.2 K) | (453.2 K) | (453.2 K) | (39.7 M) | (53.2 M) | (71.8 M) | (81.5 M) | (100.3 M) | (130 M) | (160.7 M) | (189.4 M) | (217.9 M) | (207 M) |
| SIBN | (40.1 M) | (40.1 M) | (40.1 M) | (40.1 M) | (67.9 M) | (96.1 M) | (116.7 M) | (139.7 M) | (157.2 M) | (195.6 M) | (239.3 M) | (295.8 M) | (357.1 M) | (400.4 M) | (380.4 M) |
| IRIX | (800 K) | (18.6 M) | (17.2 M) | (14.9 M) | (4.9 M) | (4.4 M) | (16.1 M) | (29 M) | (41.8 M) | (50.6 M) | (56.9 M) | (62.2 M) | (69.7 M) | (79 M) | (75.1 M) |
| SRDX | (6.5 M) | 74.6 M | 91 M | 93.9 M | 88.2 M | 98.1 M | 102.1 M | 97.6 M | 110.7 M | 111.8 M | 116.1 M | 88.8 M | 87.3 M | 100.3 M | 71.6 M |
| RCEL | (235.9 M) | (96.7 M) | (101.7 M) | (106.6 M) | (113.5 M) | (121.1 M) | (132.2 M) | (148.5 M) | (235.9 M) | (128.7 M) | (282.4 M) | (194.9 M) | (385.7 M) | (298 M) | (283.1 M) |
| CLPT | (65.5 B) | (65.5 B) | (65.5 B) | (72.8 M) | (77.3 M) | (85.7 M) | (93.9 M) | (101 M) | (107.2 M) | (112.7 M) | (119.5 M) | (133.9 M) | (150.4 M) | (172.5 M) | (181.1 M) |
| SGHT | (29.5 M) | (29.5 M) | (29.5 M) | (29.5 M) | (29.5 M) | (29.5 M) | (29.5 M) | (29.5 M) | (29.5 M) | (55.3 M) | (90 M) | (153 M) | (239.2 M) | (294.8 M) | (280.1 M) |
| TMCI | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (21.4 M) | (41.9 M) | (84.7 M) | (134.2 M) | (127.5 M) |
| FNA | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 12.4 M | (463 K) | (67.8 M) | (115.6 M) | (109.8 M) |
| VREX | 35.1 M | 35.1 M | 35.1 M | 35.1 M | 35.1 M | 35.1 M | 35.1 M | 62.4 M | 75.5 M | 16.9 M | 33.5 M | 63.8 M | 118.1 M | 70.4 M | 65.4 M |
Viemed Healthcare and related stocks such as Profound Medical Corp, Si Bone, and IRIDEX Retained Earnings description
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.My Equities
My Current Equities and Potential Positions
| Viemed Healthcare | VMD |
| Classification | Health Management |
| Location | Louisiana; U.S.A |
| Exchange | NASDAQ Exchange |
USD 8.65
Check out Viemed Healthcare Performance and Viemed Healthcare Correlation. For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Viemed Healthcare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.